Invesco
HLVX

Invesco’s HilleVax HLVX Stock Holding History

Invesco’s Portfolio HLVX Stock Details HLVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-11,913
Closed -$160K – 3854
2023
Q3 		$160K Buy
+11,913
New +$168K ﹤0.01% 3651
2023
Q1 		– Sell
-16,996
Closed -$284K – 3920
2022
Q4 		$284K Sell
16,996
-54,111
-76% -$977K ﹤0.01% 3529
2022
Q3 		$1.22M Buy
+71,107
New +$1.03M ﹤0.01% 2853

Other funds holding HLVX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Invesco's HLVX Position: Q4 2023 in Review

Invesco sold out of HilleVax (HLVX) in Q4 2023, closing a stake of 11,913 shares — an estimated $160K sold.

Invesco first reported a position in HLVX in Q3 2022 and held it in 3 quarters. The position peaked at $1.22M in Q3 2022. 69 funds tracked by Wall St. Rank hold HLVX as of Q4 2023.

  • Invesco reported no remaining HilleVax position as of Q4 2023 after selling out during the quarter.
  • Invesco sold 11,913 HilleVax shares in Q4 2023, an estimated $160K.
  • Invesco first reported a position in HilleVax in Q3 2022 and held it in 3 quarters.
  • Invesco's HilleVax position peaked at $1.22M in Q3 2022.
  • 69 funds tracked by Wall St. Rank held HilleVax as of Q4 2023.

Based on Invesco's 13F filing for Q4 2023, filed 13 Feb 2024.